SGLT2 Inhibitors: Nephroprotective Efficacy and Side Effects

SGLT2 Inhibitors: Nephroprotective Efficacy and Side Effects

The burden of diabetic kidney disease (DKD) has increased worldwide in the last two decades. Besides the growth of diabetic population, the main contributors to this phenomenon are the absence of novel nephroprotective drugs and the limited efficacy of those currently available, that is, the inhibit...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron: Carlo Garofalo, Silvio Borrelli, Maria Elena Liberti, Michele Andreucci, Giuseppe Conte, Roberto Minutolo, Michele Provenzano, Luca De Nicola
Fformat: Erthygl
Iaith:English
Cyhoeddwyd: MDPI AG 2019-06-01
Cyfres:Medicina
Pynciau:
diabetes
chronic kidney disease
GFR
albuminuria
SGLT-2 inhibitors
end stage renal disease
survival
Mynediad Ar-lein:https://www.mdpi.com/1010-660X/55/6/268

Rhyngrwyd

https://www.mdpi.com/1010-660X/55/6/268

Eitemau Tebyg